魏慎海，男，胸外科副主任醫(yī)師，副教授。畢業(yè)于北京大學(xué)醫(yī)學(xué)部，臨床醫(yī)學(xué)博士。2009年獲笹川醫(yī)學(xué)獎(jiǎng)學(xué)金資助赴日本留學(xué)，在日本國(guó)立癌癥中心中央醫(yī)院接受胸外科臨床培訓(xùn)一年，專攻胸前腫瘤微創(chuàng)手術(shù)治療（胸腔鏡、小切口）。北京醫(yī)學(xué)會(huì)胸外科分會(huì)第二屆青委委員，《胸心血管外科臨床雜志》第三屆青年編委會(huì)委員，《中華臨床醫(yī)師雜志》審稿醫(yī)生。 擅長(zhǎng)肺癌、食管癌、縱隔腫瘤等胸前腫瘤的微創(chuàng)手術(shù)治療，手術(shù)技術(shù)嫻熟，切除有效，作輕柔、細(xì)膩，損傷小，術(shù)后恢復(fù)較快。于我院先后開展并完成了上腔靜脈切除+人工血管置換術(shù)、完全胸腔鏡下肺葉切除術(shù)、各種腔鏡hybrid手術(shù)和小切口肺葉切除、胸腹腔鏡聯(lián)合食管癌切除等手術(shù)，以及對(duì)不適合手術(shù)病人的射頻消融術(shù)。對(duì)局部侵犯明顯的復(fù)雜肺癌、復(fù)雜縱隔腫瘤手術(shù)切除積累了成熟的經(jīng)驗(yàn)，對(duì)危重癥患者手術(shù)和圍手術(shù)期處理經(jīng)驗(yàn)豐富。 對(duì)于表現(xiàn)為磨玻璃影（GGOs）的早期肺癌的發(fā)現(xiàn)與治療做了深入研究，對(duì)此類不易觸摸的病灶的微創(chuàng)手術(shù)治療積累了豐富的經(jīng)驗(yàn),并率先開展了術(shù)前CT引導(dǎo)鉤針+染料定位、胸腔鏡結(jié)節(jié)切除技術(shù)，成功解決了術(shù)中無(wú)法定位的問(wèn)題。 近年開始專注于晚期肺的準(zhǔn)確治療，根據(jù)病人的身體和基因情況制定綜合治療方案，延長(zhǎng)病人生存，改善生活質(zhì)量。對(duì)肺癌淋巴結(jié)清掃與分期有獨(dú)到見解，提出以淋巴結(jié)轉(zhuǎn)移個(gè)數(shù)為基礎(chǔ)的肺癌淋巴結(jié)分期方法。先后在國(guó)際權(quán)威雜志發(fā)表論文多篇。 電話： 010-64308570（辦公室） 代表文章： 1. Wei S, Asamura H, Kawachi R, Sakurai H, Watanabe S. Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage Classification? J Thorac Oncol. 2011 Feb;6(2):310-8. 2. Wei S, Tian J, Song X, Chen Y. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer. Ann Thorac Surg. 2008 ,86(1):266-72. 3. Wei S, Cui Y, Xie M, Wang G, Kyutoku Y, Tian J, Song X, Chen Y. Atrial Arrhythmias after Pulmonary Resection: The Important Role of Pulmonary Vein Resection. Thorac Cardiovasc Surg. 2013 Jun;61(4):357-64. doi: 10.1055/s-0032-1311545. Epub 2012 Jul 13. 4. Wei S, Tian J, Song X, Chen Y. Recurrence of pulmonary sclerosing hemangioma. Thorac Cardiovasc Surg. 2008, 56(2):120-2 5. Wei S, Tian J, Song X, Chen Y. Extracorporeal instrument knotting technique for minimal access thoracic surgery. J Thorac Dis. 2015 Nov;7(11):2058-60. doi: 10.3978/j.issn.2072-1439.2015.11.30. 6. Wei S, Xie M, Tian J, Song X, Wu B, Liu L. Propensity score-matching ysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database. Radiat Oncol. 2017 Jun 13;12(1):96. doi: 10.1186/s13014-017-0836-6 7.Wei S, Tian J, Song X, Wu B, Liu L. Causes of death and competing risk ysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.J Cancer Res Clin Oncol. 2018 Jan;144(1):145-155. doi: 10.1007/s00432-017-2522-3. Epub 2017 Oct 4. 8.Xie M, Wei S, Wu X, Li X, You Y, He C.Alterations of Notch pathway in patients with adenoid cystic carcinoma of the trachea and its impact on survival.Lung Cancer. 2018 Jul;121:41-47. doi: 10.1016/j.lungcan.2018.04.020. Epub 2018 Apr 30. 9.Zhong C, Sakurai H, Wei S, Fang W, Asamura H. Sublobar resections for small-sized stage Ia lung adenocarcinoma: a Sino-Japanese multicenter study. J Thorac Dis. 2018 Feb;10(2):991-998. doi: 10.21037/jtd.2018.01.63. 10.Xie M, Wu X, Zhang J, He C, Wei S, Huang J, Fu X, Gu Y. The Prognostic Significance of Notch1 and Fatty Acid Binding Protein 7 (FABP7) Expression in Resected Tracheobronchial Adenoid Cystic Carcinoma-A Multicenter Retrospective Study. Cancer Res Treat. 2017 Nov 15. doi: 10.4143/crt.2017.337. [Epub ahead of print] 11.Xie M, He J, He C, Wei S.γ Secretase inhibitor BMS-708163 reverses resistance to EGFR inhibitor via the PI3K/Akt pathway in lung cancer.J Cell Biochem. 2015 Jun;116(6):1019-27. doi: 10.1002/jcb.25056. 12. Dib HH, Sun P, Minmin Z, Wei S, Li L.Evaluating community health centers in the City of Dalian, China: how satisfied are patients with the medical services provided and their health professionals? Health Place. 2010 May;16(3):477-88. doi: 10.1016/j.healthplace.2009.12.005. Epub 2009 Dec 16. 13. An S, Li X, Wei S, Luo C, Cui R.An unusual case of lung abscess secondary to round pneumonia caused by recurrent Klebsiella pneumoniae strain and the role of occult metastases tumor.Respir Med Case Rep. 2018 Feb 3;23:107-109. doi: 10.1016/j.rmcr.2018.01.008. eCollection 2018. 14. 魏慎海，高輝，劉桐林，陳鴻義. 乙酰肝素酶在食管癌中的表達(dá)及其與食管癌浸潤(rùn)、轉(zhuǎn)移、血管生成和PCNA指數(shù)之間的相關(guān)性. 現(xiàn)代醫(yī)學(xué)雜志，2003,13(7):1-3. 15. 魏慎海，田進(jìn)濤，宋小平，陳焱. 微創(chuàng)肌肉非損傷性開胸在肺部手術(shù)中的應(yīng)用. 實(shí)用醫(yī)學(xué)雜志，2008,24(10):1760-1761. 16. 魏慎海，田進(jìn)濤，宋小平，陳焱. 食管癌、賁門癌圍手術(shù)期液體平衡及其與術(shù)后并發(fā)癥的相關(guān)性.現(xiàn)代醫(yī)學(xué)雜志，2008, 18(14) :2022-5.